Monoclonal antibodies for the treatment of Graves' ophthalmopathy: A systematic review and meta-analysis.

Purpose: The traditional standard of care for Graves' ophthalmopathy (GO) is glucocorticoid therapy, which is associated with many long-term side effects. The aim of this systematic review and meta-analysis was to compare the traditional therapy to novel monoclonal antibodies (e.g.